| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Early detection of asymptomatic HTN; prevention of short- and long-term HTN-related morbidity |
| Risks, harm, cost | Overtesting, misclassification, unnecessary treatment, discomfort from BP measurement procedure, time involved in measuring BP |
| Benefit–harm assessment | Benefit of annual BP measurement exceeds potential harm |
| Intentional vagueness | None |
| Role of patient preferences | Increased visit time, discomfort of cuff |
| Exclusions | None |
| Strength | Moderate recommendation |
| Key references | 10,60,102,103 |
| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Early detection of asymptomatic HTN; prevention of short- and long-term HTN-related morbidity |
| Risks, harm, cost | Overtesting, misclassification, unnecessary treatment, discomfort from BP measurement procedure, time involved in measuring BP |
| Benefit–harm assessment | Benefit of annual BP measurement exceeds potential harm |
| Intentional vagueness | None |
| Role of patient preferences | Increased visit time, discomfort of cuff |
| Exclusions | None |
| Strength | Moderate recommendation |
| Key references | 10,60,102,103 |